A Switzerland-based drug manufacturer is moving to acquire a former Genentech biotech plant in California’s North Bay for $1.2 billion.
Swiss Drug Manufacturer To Pay $1 Billion for Former Genentech Site
Lonza To Invest Over $500 Million in Upgrades
By Pawan Naidu
CoStar News
March 21, 2024 | 9:16 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Midway Commerce Center
Eubanks Dr, Vacaville, CA
- Fairfield Industrial Center
2725 Low Ct, Fairfield, CA
- Companies
- Trammell Crow Company
Real Estate